Celontin (Parke-Davis Div of Pfizer Inc)
Welcome to the PulseAid listing for the Celontin drug offered from Parke-Davis Div of Pfizer Inc. This Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Parke-Davis Div of Pfizer Inc |
| NON-PROPRIETARY NAME: | methsuximide |
| SUBSTANCE NAME: | METHSUXIMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1957-02-08 |
| END MARKETING DATE: | 0000-00-00 |
Celontin HUMAN PRESCRIPTION DRUG Details:
| Item Description | Celontin from Parke-Davis Div of Pfizer Inc |
| LABELER NAME: | Parke-Davis Div of Pfizer Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 300(mg/1) |
| START MARKETING DATE: | 1957-02-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0071-0525_fe1649b6-8f71-467b-aad4-275615657668 |
| PRODUCT NDC: | 0071-0525 |
| APPLICATION NUMBER: | NDA010596 |
Other METHSUXIMIDE Pharmaceutical Manufacturers / Labelers:
